Our end-to-end viral vector capabilities

Proven processes and platforms

As a viral vector specialist with over 25 years of experience in the cell and gene therapy industry, we have a thorough understanding of the challenges you face.

We can reliably take you from laboratory concept through to clinical-grade manufacturing and large scale commercial production.

Thanks to systems and processes that have been carefully refined over time, our end-to-end viral vector services come with the assurance that all of this will happen at pace, without ever compromising on safety.

Ways we can work together

We understand that your requirements are unique and never static, and that having a flexible partner to lean on will give you an invaluable advantage.

We’re ready and equipped to join you at any or every stage of your development journey. You can depend on us to adapt to your needs and continually strive to exceed your expectations.

Tech transferred-in

Gold-standard execution of transferred-in technology and processes

Alongside our own LentiVector® and AAV platform technologies, we have the facilities and expertise to fulfil almost any development need. You define the methods and processes, and we leverage our class-leading capabilities as appropriate.

Platform project

A complete and cohesive solution

If you need a CDMO partner that you can depend on to take you from construct design and process development through to CGMP manufacturing, including fill and finish, talk to us.

When you use our fully integrated services, we’ll also support you in order to help meet global CMC regulations and guidelines, by providing the data and analytics you need to ensure you can safely and confidently take your product through clinic to market.

Contact us

Services overview

Oxford Biomedica has the capabilities to take you from construct design and process development through to 2,000L CGMP viral vector manufacturing.

We’ll also support you to navigate CMC and CGMP regulations, providing the data and analytics you need to ensure you can safely and confidently take your product to market.

Talk to us about our full scope CDMO services.

Platform	LentiVector^® Platform	AAV Platform	Adenovirus Platform
Construct and Plasmid Design			Coming soon
Analytical Development – Ability to transfer
Process Development	7L & 50L	2L, 50L, & 2,000L	7L, 50L, and 1,000L
CGMP Manufacturing	50L & 200L	500L	1,000L
QA/QC Release
Stability Studies
CMC Support
Automated Fill Finish